Cancer Genome Sequencing Market Value Strategic Analysis: Key Players Beckman Coulter, Bayer, Johnson and Johnson
Cancer genome sequencing provides a base-by-base view of the unique mutations present in cancer tissue. It enables discovery of novel cancer-related variants, containing single nucleotide variants (SNVs), copy number changes, and structural variants. By comparing tumor and normal DNA, the cancer genome sequencing can also provide a comprehensive view of changes to a specific tumor sample. Many cancer-related variants have been discovered using cancer genome sequencing. As a hypothesis-free approach, cancer genome sequencing is well suited for the discovery of...
View full press release